Francesco Frati has been appointed as the new president of the Fondazione Toscana Life Sciences (TLS), following a decis...
Neva Sgr Invests in Bio4Dreams to Boost Innovation in Life Sciences
Turin/Milan, 16 July 2024 – Neva Sgr, the venture capital arm of the Intesa Sanpaolo Group, has taken an equity st...
New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies
The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi...
Technology Transfer Necessary to Turn Scientific Discoveries into Effective Solutions
Technology transfer in the biotechnology sector is crucial for transforming scientific discoveries into effective commer...
Biotech Investments in Italy: 80% Come from Abroad
ITTBioMed by Edra and DLA Piper, supported by Lendlease, MIND, and T-Factor, recently organized the event “Patents and...
Why gene therapies must go virus-free
Gene therapies have made spectacular progress in delivering new cures for previously intractable disease, where virus ve...